1-3 of 3
Aliénor Xhaard
Close
Sort by
Journal Articles

Prospective external validation of biomarkers to predict acute graft-versus-host disease severity

Clinical Trials & Observations
Marie Robin, Raphael Porcher, David Michonneau, Laetitia Taurines, Flore Sicre de Fontbrune, Aliénor Xhaard, Bastien Oriano, Aurélien Sutra Del Galy, Régis Peffault de Latour, Gérard Socié, Marie-Hélène Schlageter
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4763–4772.
https://doi.org/10.1182/bloodadvances.2022007477
Published: 2022
Includes: Supplemental data
Journal Articles

Allogeneic reactivity–mediated endothelial cell complications after HSCT: a plea for consensual definitions

Simona Pagliuca, David Michonneau, Flore Sicre de Fontbrune, Aurélien Sutra del Galy, Aliénor Xhaard, Marie Robin, Régis Peffault de Latour, Gérard Socie
Journal: Blood Advances
Blood Adv (2019) 3 (15): 2424–2435.
https://doi.org/10.1182/bloodadvances.2019000143
Published: 2019
Journal Articles

Clinical profile, biological markers, and comorbidity index as predictors of transplant-related mortality after allo-HSCT

Clinical Trials & Observations
Aliénor Xhaard, Renato Cunha, Marc Busson, Marie Robin, Nathalie Dhedin, Tereza Coman, Aurélie Cabannes-Hamy, Flore Sicre de Fontbrune, David Michonneau, Gérard Socié, Rodrigo T. Calado, Régis Peffault de Latour
Journal: Blood Advances
Blood Adv (2017) 1 (18): 1409–1413.
https://doi.org/10.1182/bloodadvances.2017008094
Published: 2017